DCF — SYRINGA GENERAL HOSPITAL
Enterprise Value: $-29.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-29.0M
Enterprise Value
$-9.3M
PV of Cash Flows
$-19.8M
PV of Terminal Value
$-31.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $20.4M | $-1.8M | -9.0% | $-2.6M | $-2.4M |
| Year 2 | $21.1M | $-1.6M | -8.0% | $-2.5M | $-2.1M |
| Year 3 | $21.7M | $-1.4M | -7.0% | $-2.4M | $-1.8M |
| Year 4 | $22.3M | $-1.4M | -6.0% | $-2.3M | $-1.6M |
| Year 5 | $23.0M | $-1.4M | -6.0% | $-2.3M | $-1.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-29.0M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$19.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.09138577216919139
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5